Efficacy and Safety Study of Afatinib to Treat Lung Cancer Patients

Summary

The purpose of this study is to examine the efficacy and safety of using afatinib (BIBW 2992) to treat non-small cell lung cancer patients considered unfit for chemotherapy and have either suspected or confirmed Epidermal Growth Factor Receptor (EGFR) mutation.

Timeline

Start

2012-12

Primary completion

2015-08

Completion

2018-11-30

Drugs

Indications